NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY, Alberta, Oct. 20, 2023 /PRNewswire/ — Innocan Pharma Corporation (“Innocan” or the “Company”) (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.